A Cisplatin‐Selective Fluorescent Probe for Real‐Time Monitoring of Mitochondrial Platinum Accumulation in Living Cells
Authors:
- 8 December 2020
- journal article
- research article
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 60 (17) , 9264-9269
Abstract
Mitochondria have emerged as important targets for cisplatin in cancer therapy. Apart from cisplatin, anticancer Pt complexes based on similar scaffolds have also been developed to target mitochondria. Yet cellular processing of cisplatin or these mitochondria‐targeting Pt analogues remained unexplored, largely due to a lack of tools capable of probing these Pt drugs within an intracellular environment. We developed the first mitochondria‐targeted fluorescent probe for real‐time monitoring of Pt accumulation in mitochondria. We applied the probe to investigate mitochondria as cellular targets for Pt drug complexes and uncovered two distinct pathways whereby these Pt complexes could be delivered to mitochondria after cell entry.Keywords
Funding Information
- Ministry of Education - Singapore (R143-000-A66-112)
- National University of Singapore (NUS-USyd Collaboration Grant)
This publication has 39 references indexed in Scilit:
- Impact of Mitochondrion-Targeting Group on the Reactivity and Cytostatic Pathway of Platinum(IV) ComplexesInorganic Chemistry, 2018
- Base‐Resolution Analysis of Cisplatin–DNA Adducts at the Genome ScaleAngewandte Chemie, 2016
- Base‐Resolution Analysis of Cisplatin–DNA Adducts at the Genome ScaleAngewandte Chemie International Edition, 2016
- Detouring of cisplatin to access mitochondrial genome for overcoming resistanceProceedings of the National Academy of Sciences, 2014
- Subcellular targets of cisplatin cytotoxicity: An integrated viewPharmacology & Therapeutics, 2012
- Molecular mechanisms of cisplatin resistanceOncogene, 2011
- Mitochondrial Drug Targets in Cell Death and CancerCurrent Pharmaceutical Design, 2011
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancerJournal of Bioenergetics and Biomembranes, 2007
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005